DZ Bank Put 8 IVU/D 20.12.2024/ DE000DJ5F3S5 /
2024-05-28 1:35:02 PM | Chg.+0.022 | Bid2024-05-28 | Ask2024-05-28 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.023EUR | +2200.00% | 0.023 Bid Size: 4,000 |
0.073 Ask Size: 4,000 |
IVU TRAFFIC TECHN.AG... | 8.00 EUR | 2024-12-20 | Put |
GlobeNewswire
1:45 PM
NeuralAI Launches AI 3D Asset Generator with TAO Bittensor Subnet: Transforming 3D Model Creation fo...
GlobeNewswire
1:37 PM
CAE, INC. ALERT: CAE, Inc. Falls after Announcing Impairment Charges (NYSE: CAE) – Investors are Enc...
GlobeNewswire
1:35 PM
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
GlobeNewswire
1:32 PM
WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (...
GlobeNewswire
1:31 PM
SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYS...
GlobeNewswire
1:30 PM
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwri...
GlobeNewswire
1:30 PM
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
GlobeNewswire
1:30 PM
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director ...
GlobeNewswire
1:30 PM
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
1:30 PM
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
GlobeNewswire
1:30 PM
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
1:30 PM
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire
1:30 PM
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
GlobeNewswire
1:26 PM
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before...
GlobeNewswire
1:26 PM
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...